Translation and validation of a pain assessment tool for chronic pancreatitis in Chinese patients

Is this trial a fit for you?

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This observational study aims to translate, culturally adapt, and validate the Chinese version of the Comprehensive Pain Assessment Tool Short Form (COMPAT-SF) for individuals with chronic pancreatitis. A total of 356 participants diagnosed with chronic pancreatitis will be recruited from Changhai Hospital and Peking Union Medical College Hospital. Participants will complete the Chinese COMPAT-SF questionnaire twice, with a two-week gap, alongside additional pain assessments to evaluate the tool's reliability and validity. The study will employ rigorous psychometric analysis to ensure the tool is effective for measuring pain in this population.

Why it matters

Who can join: the full rules

Inclusion Criteria:

* 1\. Diagnosed with chronic pancreatitis (CP) according to the Guidelines for the Diagnosis and Treatment of Chronic Pancreatitis in China (2018 edition). Diagnosis can be confirmed by: •Primary diagnostic criteria: (i) Definitive imaging findings, and (ii) Histopathological confirmation. •Secondary diagnostic criteria: (i) Recurrent upper abdominal pain, (ii) Abnormal serum amylase levels, (iii) Pancreatic exocrine insufficiency, (iv) Pancreatic endocrine insufficiency, (v) Pathogenic gene mutations, and (vi) History of heavy alcohol consumption. •Diagnosis is confirmed if at least one primary criterion or two secondary criteria are met.
* 2\. Experience of pancreatic pain in the past 12 months

Exclusion Criteria:

* Under 18 years of age.
* No pancreatic-related pain.
* Diagnosed with pancreatic cancer or other tumors.
* Presence of communication or reading impairments.
* Refusal to participate in the study.

Where it's running

• Changhai Hospital
  Shanghai, Shanghai Municipality, China Recruiting

Study contacts

• Study coordinator: Jia-Yun Chen, Master's
• Email: 18221058071@163.com
• Phone: +86-18221058071

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

• CBT-248 safety in healthy adults for chronic pancreatitis support

  This early study tests CBT-248 in healthy adults to see if it is safe, how it behaves in the body, and whether meals affect its levels.

  Recruiting Phase 1 Cibus Therapeutics, Inc. · Melbourne, Victoria · NCT07905053

• Blood protein biomarkers to help diagnose pancreatic cancer in adults

  This study tests whether blood protein biomarkers can help detect pancreatic ductal adenocarcinoma and tell it apart from chronic pancreatitis and mucinous pancreatic lesions, and whether combining markers with CA 19-9 improves accuracy.

  Recruiting Grigore T. Popa University of Medicine and Pharmacy · Iași · NCT07875582

• Relieving a blocked pancreatic duct in chronic pancreatitis

  This pilot study tests whether clearing a blocked pancreatic duct with endoscopy can help people with chronic pancreatitis who have mild symptoms.

  Recruiting Phase 1 Mayo Clinic · Rochester, Minnesota · NCT07810309

• Understanding brain changes in chronic pancreatitis pain

  This study tests whether central nervous system changes and neuropsychological factors help explain persistent pain in adults with chronic pancreatitis.

  Recruiting Asian Institute of Gastroenterology, India · Hyderabad, Telangana · NCT07707609

• EUS-guided pancreaticobiliary procedures with the RIVOS access device

  This study tests how the RIVOS EUS access device performs during interventional procedures for pancreatic and bile duct problems in adults.

  Recruiting Orlando Health, Inc. · Orlando, Florida · NCT07696572

• Odesa Criteria 2026: tests for autoimmune pancreatitis diagnosis

  This study checks if the OC26 scoring system can accurately diagnose autoimmune pancreatitis in adults who may have AIP or related pancreatic diseases.

  Recruiting at 2 sites Military Medical Clinical Center of the Southern Region, Ukraine · Odesa and 1 other locations · NCT07536841

How to take part

1. Review the eligibility criteria above with your treating physician.
2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.